A test for anti-TNF non-responders? Few alternative RA therapies available

 
• By Mandy Jackson

Tumor necrosis factor (TNF) inhibitors, such as Amgen's Enbrel (etanercept) and AbbVie's Humira (adalimumab), are the biologics of choice to treat rheumatoid arthritis (RA) patients. But many people with the debilitating autoimmune disease don't respond to anti-TNF therapies, so what if you could identify patients early on who won't respond to those biologics?

More from Alimentary/Metabolic

More from Therapy Areas